[go: up one dir, main page]

TR201818859A2 - A combination comprising dimethyl fumarate and at least one muscle relaxant agent - Google Patents

A combination comprising dimethyl fumarate and at least one muscle relaxant agent

Info

Publication number
TR201818859A2
TR201818859A2 TR2018/18859A TR201818859A TR201818859A2 TR 201818859 A2 TR201818859 A2 TR 201818859A2 TR 2018/18859 A TR2018/18859 A TR 2018/18859A TR 201818859 A TR201818859 A TR 201818859A TR 201818859 A2 TR201818859 A2 TR 201818859A2
Authority
TR
Turkey
Prior art keywords
combination
dimethyl fumarate
muscle relaxant
relaxant agent
agent
Prior art date
Application number
TR2018/18859A
Other languages
Turkish (tr)
Inventor
Toksöz Zafer
Toksöz Ahmet
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2018/18859A priority Critical patent/TR201818859A2/en
Priority to PCT/TR2019/050957 priority patent/WO2020117161A1/en
Priority to EP19891930.0A priority patent/EP3890720A4/en
Publication of TR201818859A2 publication Critical patent/TR201818859A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş; dimetil fumarat ve en az bir kas gevşetici ajan içeren bir farmasötik kombinasyon ile ilgilidir.The present invention; relates to a pharmaceutical combination comprising dimethyl fumarate and at least one muscle relaxant.

TR2018/18859A 2018-12-07 2018-12-07 A combination comprising dimethyl fumarate and at least one muscle relaxant agent TR201818859A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2018/18859A TR201818859A2 (en) 2018-12-07 2018-12-07 A combination comprising dimethyl fumarate and at least one muscle relaxant agent
PCT/TR2019/050957 WO2020117161A1 (en) 2018-12-07 2019-11-15 A combination comprising dimethyl fumarate and at least one muscle relaxant agent
EP19891930.0A EP3890720A4 (en) 2018-12-07 2019-11-15 A combination comprising dimethyl fumarate and at least one muscle relaxant agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2018/18859A TR201818859A2 (en) 2018-12-07 2018-12-07 A combination comprising dimethyl fumarate and at least one muscle relaxant agent

Publications (1)

Publication Number Publication Date
TR201818859A2 true TR201818859A2 (en) 2020-06-22

Family

ID=70975017

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/18859A TR201818859A2 (en) 2018-12-07 2018-12-07 A combination comprising dimethyl fumarate and at least one muscle relaxant agent

Country Status (3)

Country Link
EP (1) EP3890720A4 (en)
TR (1) TR201818859A2 (en)
WO (1) WO2020117161A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT500144A1 (en) * 2004-03-05 2005-11-15 Sanochemia Pharmazeutika Ag TOLPERISON-CONTAINING PHARMACEUTICAL PREPARATION WITH CONTROLLABLE ACTIVE INGREDIENTS FOR ORAL ADMINISTRATION
CN109453133A (en) * 2013-08-26 2019-03-12 前进制药知识产权有限公司 For with the pharmaceutical composition containing dimethyl fumarate of low daily dose application
US20160228388A1 (en) 2014-11-04 2016-08-11 Adamas Pharmaceuticals, Inc. Methods of administering amantadine compositions
US11007192B2 (en) * 2016-11-07 2021-05-18 Metriopharm Ag Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of chronic progressive multiple sclerosis
TR201720406A2 (en) * 2017-12-14 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi COMBINATIONS CONTAINING A SKELETAL MUSCLE LOAER AND A MULTIPLE SCLEROSIS THERAPY

Also Published As

Publication number Publication date
EP3890720A4 (en) 2022-09-07
WO2020117161A1 (en) 2020-06-11
EP3890720A1 (en) 2021-10-13

Similar Documents

Publication Publication Date Title
MX2020005063A (en) KRAS G12C INHIBITORS.
BR112018006259A2 (en) "compressible adjunct with intermediate support structures"
MX2025009222A (en) Clec9a binding agents and use thereof
EP3863733A4 (en) HARNESS BACK PLATE AND STRAP ARRANGEMENT
EP3790861A4 (en) SENOLYTIC COMPOSITIONS AND ASSOCIATED USES
EP3870162A4 (en) SSAO INHIBITORS AND THEIR USES
UY37472A (en) SULFONILAMIDS REPLACED TO COMBAT ANIMAL PARASITES
UY37153A (en) SULFONILAMIDS REPLACED TO COMBAT ANIMAL PARASITES
MX386158B (en) 1,7-DIARYL-1,6-HEPTADIENE-3,5-DIONE DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND USE
IL286341A (en) Antibacterial agents that release gas and their uses
CO2017011295A2 (en) Vortioxetine Pyroglutamate
CR20180089A (en) USEFUL COMPOUNDS TO INHIBIT ROR-GAMMA-T
TR201720406A2 (en) COMBINATIONS CONTAINING A SKELETAL MUSCLE LOAER AND A MULTIPLE SCLEROSIS THERAPY
TR201720515A2 (en) A SOLID ORAL DOSAGE FORM CONTAINING LINAGLIPTIN
TR201819197A2 (en) A combination comprising a multiple sclerosis agent and at least one anti-epileptic agent
TR201721824A2 (en) A MODIFIED EMISSION COMBINATION CONTAINING LINAGLIPTIN AND METFORMIN
TR201818859A2 (en) A combination comprising dimethyl fumarate and at least one muscle relaxant agent
EP3976019A4 (en) HYALURONANE CONJUGATE AND ASSOCIATED USES
EP4018349A4 (en) AUTHENTICITY VERIFICATION
CY1122979T1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF FUNGIASIS
EP3986436A4 (en) CAMKII-DELTA 9 ANTAGONISTS AND ASSOCIATED USES
PE20200749A1 (en) ENAC EXPRESSION MODULATORS
DK3783210T3 (en) Generator set
TR201818864A2 (en) A COMBINATION CONTAINING DIMETHYL FUMARATE AND AT LEAST ONE ANTI-EPILEPTIC AGENT
BR112018072255A2 (en) azasteroids for tuberculosis treatment